NCT05921487

Brief Summary

Spinal cord injury (SCI) causes paralysis and muscle atrophy and leads to weight gain and obesity. Obesity directly contributes to functional impairment and cardiometabolic dysfunction. There is a critical need to reduce the growing prevalence of obesity and cardiometabolic disease after SCI. My overall objective in this project is to gather crucial feasibility data on time restricted eating (TRE), a novel form of intermittent fasting. TRE is a straightforward method to induce weight loss without the need for calorie counting. TRE allows individuals to eat all their daily calories in a time restricted window and fast outside that window. A growing body of literature supports the safety and efficacy of TRE. Given the feasibility, high adherence, and substantial benefits of TRE in able-bodied individuals, it is important to test TRE to determine its feasibility in Veterans with SCI. The investigators will first test this intervention in Veterans with paraplegia, who are at greatest risk of muscle-joint upper body injury given the need to support body weight during activity. The investigators will determine adherence to a TRE window for 6-weeks duration in a convenience sample of Veterans with paraplegia and obesity. Based on the expected outcomes of good adherence, this study will lay the groundwork for future work by informing the design of a randomized controlled trial to test the efficacy of TRE to facilitate weight loss and improve function.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
5mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Sep 2023Sep 2026

First Submitted

Initial submission to the registry

June 7, 2023

Completed
20 days until next milestone

First Posted

Study publicly available on registry

June 27, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

July 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2.8 years

First QC Date

June 7, 2023

Last Update Submit

July 1, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in the daily eating window

    Measured by questionnaire (assesses the time the participant started and stopped eating each day)

    Measured weekly from baseline to week 6

Study Arms (1)

Time Restricted Eating

EXPERIMENTAL

This is a single-arm study in a convenience sample of Veterans with paraplegia and obesity. The intervention will test adherence of participants to a TRE window with a self-selected start time. The duration of the eating window will be 10 hours, maintained through study's end (end of week 6).

Behavioral: Time Restricted Eating

Interventions

Time Restricted Eating Protocol: Subjects will be instructed to limit caloric consumption to a 10-hour TRE window. The window start-time will be self-selected (individualized). During the eating window, subjects will not be restricted on types or quantities of food consumed, and will be advised to continue their usual diets. Subjects will not be required to monitor their caloric intake. During the fasting period, subjects will be encouraged to stay hydrated and drink ample water. Outside the designated eating window, subjects are only permitted to consume medication, water, or zero-calorie herbal drinks such as unsweetened tea or black coffee.

Also known as: TRE
Time Restricted Eating

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran, age 18 to 89 years old
  • The Syracuse SCI registry includes adults only, so the youngest age of enrollment is 18. The effects of fasting on age-induced sarcopenia remain "uncertain"; therefore, the investigators will cap the age at 89 years old
  • A member of the Spinal Cord Injury/Disorder (SCI/D) registry through the Syracuse VA, including both hub and spoke sites
  • A qualifying diagnosis of SCI within the SCI/D registry
  • Neurologic level of injury from T1 to S5, based on most recent Status Update or ASIA examination, or a diagnosis of a hereditary form of paraplegia (such as familial spastic paraplegia or hereditary spastic paraplegia)
  • ASIA Impairment Scale grade A-D
  • Chronic SCI (\> 1 year from date of SCI or diagnosis of SCI)
  • BMI \> 22 - the BMI used to diagnose obesity in individuals with SCI
  • Mean eating window of at least 10 hours per day

You may not qualify if:

  • Females who are pregnant (tested via urinary hCG), planning to become pregnant in the next 6 months, or breast-feeding
  • A member of the SCI/D registry through the Syracuse VA, with a qualifying diagnosis of MS or ALS
  • Diagnosis of heart failure
  • Diagnosis of diabetes mellitus, type 1
  • Diagnosis of diabetes mellitus, type 2, and on insulin or other antidiabetic agent with high incidence of hypoglycemia
  • o Of note, antidiabetic agents with low incidence of hypoglycemia are: metformin, GLP-1 receptor agonists, SGLT2 inhibitors, DPP4 inhibitors, alpha glucosidase inhibitors, thiazolidinediones (as discussed with VA pharmacist)
  • Diagnosis of End Stage Renal Disease
  • Diagnosis of dementia
  • Diagnosis of orthostatic hypotension and prescribed midodrine or fludrocortisone
  • History of syncopal episode in the month prior to the study
  • History of significant weight loss (\> 10% body weight) in the month prior to the study
  • History of eating disorders (e.g., anorexia or bulimia) within the last five years, or clearance from a mental health provider
  • History of active suicidal ideation in the last six months, or clearance from a mental health provider
  • Currently prescribed weight loss medication (e.g., liraglutide)
  • Currently prescribed corticosteroids
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Syracuse VA Medical Center, Syracuse, NY

Syracuse, New York, 13210-2716, United States

Location

MeSH Terms

Conditions

Spinal Cord InjuriesObesity

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemWounds and InjuriesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Geoffrey V Henderson, MD

    Syracuse VA Medical Center, Syracuse, NY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Intervention: This is a single-arm study in a convenience sample of Veterans with paraplegia and obesity. Research Design: Those with mean eating windows of at least 10 hours per day will be eligible to participate in the TRE intervention. Tests for adherence (food log) will be collected.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 7, 2023

First Posted

June 27, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

July 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

A de-identified, anonymized dataset will be created and shared upon written request for appropriate scientific reasons.

Shared Documents
SAP
Time Frame
The dataset will be available following publication of the primary manuscript for this project.
Access Criteria
The dataset will be released upon written request for scientific purposes including re-analysis and validation of results.

Locations